DNX2401 and Temozolomide: Clinical Trials

1 trial of DNX2401 and Temozolomide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow DNX2401 and Temozolomide: new trials by email Literature Review of DNX2401 and Temozolomide trials Research Report on DNX2401 and Temozolomide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
DNX2401 and Temozolomide - Glioblastoma Multiforme, Recurrent Tumor
Phase 1CompletedClinica Universidad de Navarra, Universidad de Navarra312013-09-012017-10-24

Conditions studied

Glioblastoma (1)  ·  Recurrence (1)

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra (1)

Countries

Spain (1)

Top investigators

Sonia Tejada, MD, PhD (1)